| Systematic (IUPAC) name | |
|---|---|
| (5R)-3-[4-[1-[(2S)-2,3-Dihydroxypropanoyl]-3,6-dihydro-2H-pyridin-4-yl]-3,5-difluorophenyl]-5-(1,2-oxazol-3-yloxymethyl)-1,3-oxazolidin-2-one | |
| Clinical data | |
| Pregnancy cat. | ? |
| Legal status | ? |
| Identifiers | |
| CAS number | 252260-02-9 |
| ATC code | None |
| PubChem | CID 213049 |
| UNII | 82V2M8K24R |
| Synonyms | AZD2563 |
| Chemical data | |
| Formula | C21H21F2N3O7 |
| Mol. mass | 465.40 g/mol |
| SMILES | eMolecules & PubChem |
| |
|
Posizolid is an oxazolidinone antibiotic under investigation by AstraZeneca for the treatment of bacterial infections. At a concentration of 2 mg/L it inhibited 98% of all Gram-positive bacteria tested in vitro.[1]
| This systemic antibacterial-related article is a stub. You can help Wikipedia by expanding it. |
|
|||||||||||||||||||||||||||||||||
This entry is from Wikipedia, the leading user-contributed encyclopedia. It may not have been reviewed by professional editors (see full disclaimer)